AcouSort receives 1.25 million SEK in Vinnova funding for the development of individualized stem cell treatments

AcouSort AB (publ) (”AcouSort”) receives funding from Vinnova for the project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from research to a clinical setting. The project is planned to run over five years and generate revenues of 1.25 million SEK to AcouSort.

Read Presss release as PDF here

Läs pressmeddelande som PDF här